Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Radiol. Sep 28, 2010; 2(9): 354-357
Published online Sep 28, 2010. doi: 10.4329/wjr.v2.i9.354
Hyperdense artery sign on computed tomography in acute ischemic stroke
Ulf Jensen-Kondering, Christian Riedel, Olav Jansen
Ulf Jensen-Kondering, Christian Riedel, Olav Jansen, Institute of Neuroradiology, University of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus 41, 24105 Kiel, Germany
Author contributions: All authors made a substantial contribution to the conception and design of the manuscript, drafting the article or revising it.
Correspondence to: Dr. Ulf Jensen-Kondering, Institute of Neuroradiology, University of Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus 41, 24105 Kiel, Germany.
Telephone: +49-431-5974798 Fax: +49-431-5974913
Received: July 29, 2010
Revised: August 24, 2010
Accepted: August 31, 2010
Published online: September 28, 2010


Despite the advent and growing availability of magnetic resonance imaging, the imaging modality of choice in the acute care of stroke patients in many institutions remains computed tomography. The hyperdense artery sign is the earliest marker of acute ischemic stroke. In this short review, we discuss the pathology, incidence, clinical aspects, imaging findings, significance and future questions that need to be addressed concerning this important sign.

Key Words: Computed tomography, Early ischemic signs, Hyperdense artery, Stroke


Computed tomography still remains the key imaging diagnostic tool in the work-up of patients with acute stroke. This is mainly due to its wide availability and quick and robust performance. The hyperdense artery sign (HAS) has long been known as an indicator of occluding clots in cases of acute ischemia on non-enhanced cranial computed tomography (NECCT). A hyperdense cerebral artery in the setting of acute ischemic stroke was first reported by Gács et al[1] in 1983. It is the earliest sign, and is visible long before parenchymal changes which are known as early ischemic signs. In principle, it becomes visible with the onset of occlusion in a cerebral vessel. The histopathological correlate for the HAS is a thrombus occluding the vessel[2]. When a thrombus is forming, the local hematocrit level rises due to extrusion of plasma leaving clotted cells and debris behind. Thus, the attenuation rises from less than 40 HU in flowing blood to approximately 80 HU. In contrast to atheromatous calcifications (see below) a hyperdensity caused by the HAS is reversible[3].


The HAS has always been described as having a high specificity (90%-100%). Nonetheless, other causes of HAS have been described. Due to the linear correlation between attenuation and hematocrit level it is easily understood that a high hematocrit level leads to hyperdense arteries[4,5]. Other than with the HAS not only one vessel is affected but all intracranial arteries and veins (Figure 1). Naturally, when contrast agent is injected, all intracranial vessels appear hyperdense on NECCT, either because a short time has elapsed after injection or because of increased retention, e.g. because of renal impairment. As another possible cause for a HAS, Koo et al[6] described a hyperdense middle cerebral artery (MCA) due to viral infection. Of course, other objects such as plaque of atheromatous origin[7] or foreign bodies, e.g. catheter fragments can cause a hyperdense artery. There are reports of hyperdense arteries in the setting of dissection[8-12]. It is not clear whether the pathological correlate of the HAS in these cases is the intramural hematoma or the intraluminal thrombus. Hypodense brain parenchyma due to infection or tumors (Figure 2) surrounding the vessel can give the impression of a pseudohyperdense vessel[13]. Additionally, atheromatous vessel calcifications can raise vessel attenuation and it can be difficult to discriminate intraluminal from mural hyperdensities. To establish objective criteria for HAS, Koo et al[6] defined a ratio of 1.2 when compared to the non-affected contralateral vessel or an absolute value of > 43 HU.

Figure 1
Figure 1 Non-enhanced cranial computed tomography of a 58-year-old female patient with a hematocrit of 58%. Note that all depicted intracranial arteries and veins appear hyperdense (curved arrows). No contrast agent was applied prior to the scan.
Figure 2
Figure 2 Pseudohyperdense right middle cerebral artery (arrows) due to underlying infection of the temporal lobe.

The HAS was first described in the MCA[1]. This is not surprising as the MCA is the most commonly affected vascular territory in strokes. Additionally, the MCA is the intracranial artery with the largest diameter which enables the detection of a hyperdensity in this vessel. Furthermore, almost its whole length runs within the imaging plane. There is an abundance of literature on the hyperdense MCA sign[14-25] (Figure 3). Other locations are less frequently reported. It has been described in the carotid artery (HICAS)[26], MCA distal branches as the “dot sign”[27,28], the anterior cerebral artery (HACAS)[29,30] (Figure 4), the posterior cerebral artery (HPCAS)[1,31,32] (Figure 5), the basilar artery (HBAS)[33-36] (Figure 6), and the vertebral artery[8].

Figure 3
Figure 3 Hyperdense left middle cerebral artery sign (arrow) in a patient presenting with signs of left hemispheric stroke.
Figure 4
Figure 4 Hyperdense left anterior cerebral artery (arrow) in a patient who presented with right-sided hemiparesis.
Figure 5
Figure 5 Hyperdense right fetal posterior cerebral artery (arrow) in a patient who presented with left sided homonymous hemianopia and left sided hemiparesis.
Figure 6
Figure 6 Hyperdense basilar artery (arrow) in a patient who was found unconscious.

The clinical presentation correlates with the localization of the HAS except for HBAS. Sudden onset of focal neurological symptoms (HICAS: hemispheric syndrome; HMCAS and “dot sign”: brachio-facial dominant paresis, aphasia; HACAS: crural dominant paresis; HPCAS: visual field loss, hemiparesis) can guide the clinician to the affected artery.

In the case of an occluded basilar artery, the patient usually presents with loss of consciousness. The differential diagnosis include a variety of non-neurological causes and vary from heat exhaustion to intoxication, and only radiological recognition of the HBAS can propel the patient to appropriate recanalization therapy, i.e. intra-arterial thrombolysis (IAT) and/or intravenous thrombolysis (IVT).


The HAS has always been associated with a poor clinical outcome, large volume strokes, and severe neurological deficits[18]. This is probably caused by larger amounts of thrombus becoming visible on NECCT as an HAS, whereas smaller clots are invisible due to partial volume effects. Some studies have reported on the benefit of IVT in patients exhibiting a HAS[14-17], while others do not[18-22]. Two studies suggested that patients with a HAS benefited more from IAT as opposed to IVT[23,24]. This observation is in line with the afore-mentioned hypothesis that only large amounts of thrombus are visible on NECCT. What has prevented the HAS from becoming a more reliable marker of acute ischemic stroke is the fact that despite its high specificity it displays a low sensitivity of around 30%[25]. The reason for that is probably because of the large slice thickness in routine NECCT compared to the size of the vessels in question. On routine NECCT a slice thickness of 5 mm is not uncommon, while the MCA has a diameter of 2-3 mm. This discrepancy results in partial volume effects which blur the intraluminal hyperdensity. Two recent studies[37,38] examined the value of thin slice NECCT reconstructed on multidetector CT. The results in both studies were a striking rise in sensitivity to approximately 80%-100%. Riedel et al[38] also found a good correlation between vessel hyperdensity and thrombus volume when compared to computed tomography angiography (CTA).


If NECCT is capable of reliably detecting thrombus, an interesting question for future studies may be: is there a cut-off value for the length of intraluminal thrombus beyond which IVT proves ineffective? In these cases, IAT may be the therapeutic option of choice. A further question is whether it is possible to automatically detect thrombus and measure its amount? NECCT would be a powerful and widely available tool to address these issues. Therefore, ideally prospective studies including patients suffering from acute ischemic stroke should compare luminal contrast gaps due to intravascular clots as detected in CTA images with thin slice NECCT images showing thrombus as an HAS. In order to find a threshold of clot burden beyond which it is not possible to recanalize occluded vessels by IVT, the patients would have to be followed by imaging studies (either MRA, CTA or transcranial ultrasound) at a fixed time interval after therapy in order to investigate if the recanalization was successful or if it failed.


Peer reviewer: Kennith F Layton, MD, FAHA, Division of Neuroradiology and Director of Interventional Neuroradiology, Department of Radiology, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246, United States

S- Editor Cheng JX L- Editor Webster JR E- Editor Zheng XM

1.  Gács G, Fox AJ, Barnett HJ, Vinuela F. CT visualization of intracranial arterial thromboembolism. Stroke. 1983;14:756-762.  [PubMed]  [DOI]
2.  Rutgers DR, van der Grond J, Jansen GH, Somford DM, Mali WP. Radiologic-pathologic correlation of the hyperdense middle cerebral artery sign. A case report. Acta Radiol. 2001;42:467-469.  [PubMed]  [DOI]
3.  Schuknecht B, Ratzka M, Hofmann E. The "dense artery sign"--major cerebral artery thromboembolism demonstrated by computed tomography. Neuroradiology. 1990;32:98-103.  [PubMed]  [DOI]
4.  Rauch RA, Bazan C 3rd, Larsson EM, Jinkins JR. Hyperdense middle cerebral arteries identified on CT as a false sign of vascular occlusion. AJNR Am J Neuroradiol. 1993;14:669-673.  [PubMed]  [DOI]
5.  Ben Salem D, Osseby GV, Rezaizadeh-Bourdariat K, Pastural G, Martin D, Brunotte F, Moreau T, Giroud M, Binnert D. [Spontaneous hyperdense intracranial vessels seen on CT scan in polycythemia cases]. J Radiol. 2003;84:605-608.  [PubMed]  [DOI]
6.  Koo CK, Teasdale E, Muir KW. What constitutes a true hyperdense middle cerebral artery sign? Cerebrovasc Dis. 2000;10:419-423.  [PubMed]  [DOI]
7.  Oppenheim RE, Felsberg GJ. Images in clinical medicine. Cerebral embolism of probable aortic origin. N Engl J Med. 2008;358:e17.  [PubMed]  [DOI]
8.  Provenzale JM, Barboriak DP, Taveras JM. Exercise-related dissection of craniocervical arteries: CT, MR, and angiographic findings. J Comput Assist Tomogr. 1995;19:268-276.  [PubMed]  [DOI]
9.  Oshiro S, Ohnishi H, Ohta M, Tsuchimochi H. Pediatric blunt carotid injury--case report. Neurol Med Chir (Tokyo). 2003;43:134-137.  [PubMed]  [DOI]
10.  Santarius T, Menon DK. Images in clinical medicine. Carotid-artery thrombosis secondary to basal skull fracture. N Engl J Med. 2003;349:e5.  [PubMed]  [DOI]
11.  Yakushiji Y, Haraguchi Y, Soejima S, Takase Y, Uchino A, Koizumi S, Kuroda Y. A hyperdense artery sign and middle cerebral artery dissection. Intern Med. 2006;45:1319-1322.  [PubMed]  [DOI]
12.  Hsu KC, Kao HW, Chen SJ. Backward somersault as a cause of childhood stroke: a case report of isolated middle cerebral artery dissection in an adolescent boy. Am J Emerg Med. 2008;26:519.e3-519.e5.  [PubMed]  [DOI]
13.  Jha B, Kothari M. Pearls & oy-sters: hyperdense or pseudohyperdense MCA sign: a Damocles sword? Neurology. 2009;72:e116-e117.  [PubMed]  [DOI]
14.  Manelfe C, Larrue V, von Kummer R, Bozzao L, Ringleb P, Bastianello S, Iweins F, Lesaffre E. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke. 1999;30:769-772.  [PubMed]  [DOI]
15.  Tartaglia MC, Di Legge S, Saposnik G, Jain V, Chan R, Bussière M, Hachinski V, Frank C, Hesser K, Pelz D. Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA. Can J Neurol Sci. 2008;35:583-587.  [PubMed]  [DOI]
16.  Georgiadis D, Wirz F, von Büdingen HC, Valko P, Hund-Georgiadis M, Nedeltchev K, Rousson V, Baumgartner RW. Intravenous thrombolysis in stroke patients with hyperdense middle cerebral artery sign. Eur J Neurol. 2009;16:162-167.  [PubMed]  [DOI]
17.  Tei H, Uchiyama S, Usui T. Predictors of good prognosis in total anterior circulation infarction within 6 h after onset under conventional therapy. Acta Neurol Scand. 2006;113:301-306.  [PubMed]  [DOI]
18.  Abul-Kasim K, Brizzi M, Petersson J. Hyperdense middle cerebral artery sign is an ominous prognostic marker despite optimal workflow. Acta Neurol Scand. 2010;122:132-139.  [PubMed]  [DOI]
19.  Aries MJ, Uyttenboogaart M, Koopman K, Rödiger LA, Vroomen PC, De Keyser J, Luijckx GJ. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. J Neurol Sci. 2009;285:114-117.  [PubMed]  [DOI]
20.  Nichols C, Khoury J, Brott T, Broderick J. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. J Stroke Cerebrovasc Dis. 2008;17:64-68.  [PubMed]  [DOI]
21.  Kharitonova T, Ahmed N, Thorén M, Wardlaw JM, von Kummer R, Glahn J, Wahlgren N. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis. 2009;27:51-59.  [PubMed]  [DOI]
22.  Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Divani AA. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology. 2006;66:1171-1174.  [PubMed]  [DOI]
23.  Mattle HP, Arnold M, Georgiadis D, Baumann C, Nedeltchev K, Benninger D, Remonda L, von Büdingen C, Diana A, Pangalu A. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke. 2008;39:379-383.  [PubMed]  [DOI]
24.  Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis. 2004;17:182-190.  [PubMed]  [DOI]
25.  Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke. 1992;23:317-324.  [PubMed]  [DOI]
26.  Ozdemir O, Leung A, Bussiére M, Hachinski V, Pelz D. Hyperdense internal carotid artery sign: a CT sign of acute ischemia. Stroke. 2008;39:2011-2016.  [PubMed]  [DOI]
27.  Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia. Stroke. 2001;32:84-88.  [PubMed]  [DOI]
28.  Leary MC, Kidwell CS, Villablanca JP, Starkman S, Jahan R, Duckwiler GR, Gobin YP, Sykes S, Gough KJ, Ferguson K. Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study. Stroke. 2003;34:2636-2640.  [PubMed]  [DOI]
29.  del Saz-Saucedo P, Maestre-Moreno JF, Vatz KA, Pérez-Navarro MJ, Fernández CC, Hernás-Navidad R, Ortega-Moreno A. [Sign of hyperdense and hyperintense anterior cerebral artery]. Neurologia. 2007;22:184-186.  [PubMed]  [DOI]
30.  Jensen UR, Weiss M, Zimmermann P, Jansen O, Riedel C. The hyperdense anterior cerebral artery sign (HACAS) as a computed tomography marker for acute ischemia in the anterior cerebral artery territory. Cerebrovasc Dis. 2010;29:62-67.  [PubMed]  [DOI]
31.  Krings T, Noelchen D, Mull M, Willmes K, Meister IG, Reinacher P, Toepper R, Thron AK. The hyperdense posterior cerebral artery sign: a computed tomography marker of acute ischemia in the posterior cerebral artery territory. Stroke. 2006;37:399-403.  [PubMed]  [DOI]
32.  Bettle N, Lyden PD. Thrombosis of the posterior cerebral artery (PCA) visualized on computed tomography: the dense PCA sign. Arch Neurol. 2004;61:1960-1961.  [PubMed]  [DOI]
33.  Hankey GJ, Khangure MS, Stewart-Wynne EG. Detection of basilar artery thrombosis by computed tomography. Clin Radiol. 1988;39:140-143.  [PubMed]  [DOI]
34.  Castillo M, Falcone S, Naidich TP, Bowen B, Quencer RM. Imaging in acute basilar artery thrombosis. Neuroradiology. 1994;36:426-429.  [PubMed]  [DOI]
35.  Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturzenegger M, Schuknecht B, Mattle HP. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry. 2004;75:857-862.  [PubMed]  [DOI]
36.  Goldmakher GV, Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Halpern EF, Chou MJ, Biagini T, Smith WS, Harris GJ. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke. 2009;40:134-139.  [PubMed]  [DOI]
37.  Kim EY, Lee SK, Kim DJ, Suh SH, Kim J, Heo JH, Kim DI. Detection of thrombus in acute ischemic stroke: value of thin-section noncontrast-computed tomography. Stroke. 2005;36:2745-2747.  [PubMed]  [DOI]
38.  Riedel CH, Jensen U, Rohr A, Tietke M, Alfke K, Ulmer S, Jansen O. Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced Computed Tomography reconstructions. Stroke. 2010;41:1659-1664.  [PubMed]  [DOI]